secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001641172-25-014652
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 10M shares to CEO in settlement of $50K accrued salary
-----------------------------------------------------------------------------

- Issued 10,000,000 common shares to CEO David R. Koos as settlement for $50,000 of accrued unpaid salary.
- Shares issued under Section 4(a)(2) exempt offering; no underwriters or commissions paid.
- Settlement agreement (Ex-10.1) reveals total unpaid salary of $457,113.19; only $50K settled with shares.
- Post-issuance, shares outstanding increased to 31,554,704 from ~21.6M, a ~46% dilution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225014652/0001641172-25-014652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225014652/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer